Pfizer says its antiviral pill can cut 89% of COVID hospitalizations and deaths Posted inantiviralCOVID-19drugdrug developmentInfectious diseaseoralpandemicPfizerpublic healthScience Posted byBeth Mole 11/06/2021 The oral COVID-19 drug is the second to produce promising trial results.
